SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-19-003296
Filing Date
2019-10-21
Accepted
2019-10-18 19:28:57
Documents
5
Period of Report
2019-10-16
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K galapharma_8k-10162019.htm 8-K 20242
2 RESIGNATION OF MAQSOOD REHMAN galapharma_ex1701.htm EX-17.1 5637
3 RESIGNATION OF REINIER HOOGENRAAD galapharma_ex1702.htm EX-17.2 2404
4 GRAPHIC image_003.jpg GRAPHIC 4681
5 GRAPHIC image_002.jpg GRAPHIC 1528
  Complete submission text file 0001683168-19-003296.txt   38833
Mailing Address 18881 VON KARMAN AVE. SUITE 1440 IRVINE CA 92612
Business Address 18881 VON KARMAN AVE. SUITE 1440 IRVINE CA 92612 949-851-9261
Gala Pharmaceutical Inc. (Filer) CIK: 0001513403 (see all company filings)

IRS No.: 421771014 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 8-K | Act: 34 | File No.: 000-55998 | Film No.: 191158600
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl